Cilatus BioPharma's Corporate Majority Round

Cilatus BioPharma raised a round of funding on January 04, 2017. Investors include Malin Corporation.

Cilatus BioPharma specializes in the management and services of CMC Development, CMC Regulatory Affairs, Quality Management, Engineering, Validation/Qualification, and Manufacturing for biological pro…

Articles about Cilatus BioPharma's Corporate Majority Round: